Amicus Therapeutics (FOLD) Total Assets by Year
Amicus Therapeutics, Inc closed fiscal year 2025 with $949.9M in total assets, $675.6M in total liabilities and $274.2M in shareholder equity. Total assets rose 21.0% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Amicus Therapeutics, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
FOLD Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $949.9M+21.0% | $785.0M+0.9% | $777.9M+7.4% | $724.2M-20.0% | $905.1M+2.1% | $886.5M+4.3% | $850.2M+7.6% | $790.0M+26.0% | $627.0M-39.5% | $1.0B+14.1% | $908.4M+332.6% | $210.0M+64.6% | $127.6M+15.9% | $110.1M+57.7% | $69.8M |
| Total Liabilities | $675.6M+14.3% | $591.0M-4.3% | $617.7M+2.8% | $601.1M+0.6% | $597.8M-0.4% | $600.1M+60.6% | $373.8M-16.4% | $447.0M+63.0% | $274.2M-59.5% | $676.7M+20.7% | $560.5M+538.5% | $87.8M+7.3% | $81.8M+100.2% | $40.9M+1.7% | $40.2M |
| Total Equity | $274.2M+41.3% | $194.0M+21.1% | $160.2M+30.2% | $123.0M-60.0% | $307.4M+7.3% | $286.4M-39.9% | $476.4M+38.9% | $342.9M-2.8% | $352.9M-2.0% | $360.2M+3.5% | $347.8M+184.7% | $122.2M+167.0% | $45.8M-33.9% | $69.2M+133.9% | $29.6M |
FOLD Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $949.9M+21.0% | $868.8M+10.5% | $815.3M+8.8% | $789.8M+9.4% | $785.0M+0.9% | $786.6M+2.9% | $749.5M+2.7% | $721.8M+3.0% | $777.9M+7.4% | $764.1M+0.6% | $730.1M-8.8% | $700.5M-15.3% |
| Total Liabilities | $675.6M+14.3% | $638.4M+5.0% | $611.0M-1.0% | $596.3M+0.9% | $591.0M-4.3% | $607.7M-3.7% | $617.0M-0.3% | $591.1M-1.1% | $617.7M+2.8% | $630.8M+0.6% | $618.5M-1.4% | $597.9M+1.6% |
| Total Equity | $274.2M+41.3% | $230.4M+28.9% | $204.3M+54.2% | $193.6M+48.1% | $194.0M+21.1% | $178.8M+34.2% | $132.5M+18.8% | $130.7M+27.4% | $160.2M+30.2% | $133.2M+0.5% | $111.6M-35.7% | $102.6M-57.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Amicus Therapeutics, Inc financials
Frequently Asked Questions
Amicus Therapeutics, Inc closed fiscal year 2025 with $949.9M in total assets, $675.6M in total liabilities and $274.2M in shareholder equity.
Amicus Therapeutics, Inc (FOLD) total assets rose by 21.0% year over year, from $785.0M to $949.9M in fiscal year 2025.
Across the 15 fiscal years this page covers, Amicus Therapeutics, Inc (FOLD) total assets went from $69.8M in fiscal year 2011 to $949.9M in fiscal year 2025.
Amicus Therapeutics, Inc (FOLD) reported $949.9M in total assets in Q4 2025. This represents an increase of 21.0% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Amicus Therapeutics, Inc (FOLD) reported on that line in every period on record.